![Cynthia Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cynthia Smith
Direktor/Vorstandsmitglied bei
AKEBIA THERAPEUTICS, INC.
Vermögen: 860 578 $ am 31.05.2026
Profil
Cynthia Smith is currently an Independent Director at Agios Pharmaceuticals, Inc. since 2022, Akebia Therapeutics, Inc. since 2018, Spero Therapeutics, Inc. since 2019, Protara Therapeutics, Inc. since 2021, and Tvardi Therapeutics, Inc. starting in 2025.
Ms. Smith is also a Director at the French-American Foundation.
Former positions include Executive Director-Healthcare System at Merck & Co., Inc. from 2000 to 2008, Independent Director at Dicerna Pharmaceuticals, Inc. from 2018 to 2021, Independent Director at Nivalis Therapeutics, Inc. from 2016 to 2017, Chief Commercial Officer at ZS Pharma, Inc. from 2013 to 2016, and VP-Market Access & Commercial Development at Affymax, Inc. from 2008 to 2013.
Education includes undergraduate studies at The University of North Carolina at Chapel Hill, an MBA from The Wharton School of the University of Pennsylvania, and graduate studies at the Eagleton Institute of Politics.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.06.2026 | 15’230 ( 0.03% ) | 447 762 $ | 31.05.2026 | |
| 23.06.2026 | 75’000 ( 0.13% ) | 212 250 $ | 31.05.2026 | |
| 17.06.2026 | 196’633 ( 0.07% ) | 200 566 $ | 31.05.2026 | |
| 15.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
-.--% | 09.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Cynthia Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.08.2018 |
| SPERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.03.2019 |
| PROTARA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2021 |
| AGIOS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 11.08.2022 |
French-American Foundation
 French-American Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a non profit organization for social services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Cynthia Smith
| Unternehmen | Position | Ende |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 28.12.2021 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Direktor/Vorstandsmitglied | 01.07.2017 |
| ZS PHARMA INC | Corporate Officer/Principal | 01.12.2016 |
| AFFYMAX, INC. | Corporate Officer/Principal | 01.03.2013 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Cynthia Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
French-American Foundation
French-American Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a non profit organization for social services | Miscellaneous |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eagleton Institute of Politics
 Eagleton Institute of Politics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Wählen Sie MarketScreener 
